Brooks Laboratories Ltd - BROOKS LAB. Share Price

Sector: Pharmaceuticals | ISIN: INE650L01011
₹ 121.55 (-0.73%) icon23 Feb, 2024, 12:00:00 AM
Open
₹ 122.90
Prev. Close
₹ 122.45
Turnover(lac)
₹ 0.00
Day's High
₹ 126.95
Day's Low
₹ 120.90
52 Wk High
₹ 185.70
52 Wk Low
₹ 56.95
Book Value
₹ 26.51
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 319.03
P/E
0.00
EPS
0.19
Div. Yield
0.00

Brooks Laboratories Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/23/2024 12:00:00 AM

    ₹ 121.55 -0.90 -0.73
  • Open
  • ₹ 122.9
  • Prev. Close
  • ₹ 122.45
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 126.95
  • Day's Low
  • ₹ 120.9
  • 52 Week's High
  • ₹ 185.7
  • 52 Week's Low
  • ₹ 56.95
  • Book Value
  • ₹ 26.51
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 319.03
  • P/E
  • 0
  • EPS
  • 0.19
  • Divi. Yield
  • 0

Brooks Laboratories Ltd Corporate Actions

24 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2024

12:00 AM

16 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2023

12:00 AM

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Aug , 2023

12:00 AM

AGM

Announcement date: 30 Aug , 2023

View Details

23 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

18 Jul , 2023

12:00 AM

03 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

30 Aug , 2023

12:00 AM

BookCloser

View Details

Brooks Laboratories Ltd News and Update

Image not found
  • 1 day ago |
  • 12:06 AM

Think and Learn Pvt Ltd, the company that owns Byju's, is accused of breaking India's foreign exchange rules

Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Brooks Laboratories Ltd SHAREHOLDING SNAPSHOT
24 February , 2024 | 12:18 PM

PROMOTER - TOTAL63.59%

Indian: 63.59%

Foreign: 0%

NON-PROMOTER - TOTAL 36.41%

Institutions: 3.86%

Non-Institutions: 32.55%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Brooks Laboratories Ltd FINANCIALS

Brooks Laboratories Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Brooks Laboratories Ltd

  • Rajnish Kumar Bedi
  • Independent Director
  • Deepak Mahajan
  • Independent Director
  • Sonia Gupta
  • Independent Director
  • Jitendra Pratap Singh
  • Whole Time Director
  • Durga Sankar Maity
  • Whole-time Director
  • Mr. Bhushan Singh Rana
  • Whole-time Director
  • JAI PRAKASH VAIDYA
  • Company Sec. & Compli. Officer

Summary

Brooks Laboratories Ltd is a pharmaceutical manufacturing company working on contract basis. The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat. Both the units are cGMP compliant in conformity with national and international standards. The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc. Their product portfolio presently comprises of 28 Injectables, 19 Tablets and 2 Dry Syrups which are marketed domestically.The companys manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes. At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India.The companys major clients are companies like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd, Sanat Products Ltd, Hetero Healthcare Ltd, Medley Pharmaceuticals, Wockhardt Ltd, Parental Drugs, Chanderbhagat Pharma and Alembic Ltd etc. Their major suppliers of raw materials are Rajasthan Antibiotics Ltd, Aurobindo Pharma Ltd, DSM Anti Infectives Ltd and Qilu Pharmaceutical Company Ltd.Brooks Laboratories Ltd was incorporated on January 23, 2002. The company was initially promoted for manufacturing... Read More


Reports by Brooks Laboratories Ltd


Reports by Brooks Laboratories Ltd

Company FAQ

No Record Found